KR100695834B1 - 마크로리드의 안정화 방법 - Google Patents

마크로리드의 안정화 방법 Download PDF

Info

Publication number
KR100695834B1
KR100695834B1 KR1020017007009A KR20017007009A KR100695834B1 KR 100695834 B1 KR100695834 B1 KR 100695834B1 KR 1020017007009 A KR1020017007009 A KR 1020017007009A KR 20017007009 A KR20017007009 A KR 20017007009A KR 100695834 B1 KR100695834 B1 KR 100695834B1
Authority
KR
South Korea
Prior art keywords
rapamycin
ascomycin
derivative
antioxidant
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020017007009A
Other languages
English (en)
Korean (ko)
Other versions
KR20010101128A (ko
Inventor
프랑쏘와 나바로
사무엘 쁘띠
가이 스톤
Original Assignee
노파르티스 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26314797&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR100695834(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 노파르티스 아게 filed Critical 노파르티스 아게
Publication of KR20010101128A publication Critical patent/KR20010101128A/ko
Application granted granted Critical
Publication of KR100695834B1 publication Critical patent/KR100695834B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
KR1020017007009A 1998-12-07 1999-12-06 마크로리드의 안정화 방법 Expired - Lifetime KR100695834B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9826882.4 1998-12-07
GBGB9826882.4A GB9826882D0 (en) 1998-12-07 1998-12-07 Organic compounds
GBGB9904934.8A GB9904934D0 (en) 1998-12-07 1999-03-04 Organic compounds
GB9904934.8 1999-03-04

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020067017352A Division KR20060096477A (ko) 1998-12-07 1999-12-06 마크로리드의 안정화 방법

Publications (2)

Publication Number Publication Date
KR20010101128A KR20010101128A (ko) 2001-11-14
KR100695834B1 true KR100695834B1 (ko) 2007-03-19

Family

ID=26314797

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020017007009A Expired - Lifetime KR100695834B1 (ko) 1998-12-07 1999-12-06 마크로리드의 안정화 방법
KR1020067017352A Ceased KR20060096477A (ko) 1998-12-07 1999-12-06 마크로리드의 안정화 방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020067017352A Ceased KR20060096477A (ko) 1998-12-07 1999-12-06 마크로리드의 안정화 방법

Country Status (38)

Country Link
US (5) US6605613B2 (https=)
EP (4) EP2269651A3 (https=)
JP (3) JP3805625B2 (https=)
KR (2) KR100695834B1 (https=)
CN (2) CN1876657B (https=)
AR (3) AR026102A1 (https=)
AT (1) ATE365051T1 (https=)
AU (1) AU759219B2 (https=)
BE (1) BE1012869A3 (https=)
BR (1) BR9915986A (https=)
CA (3) CA2351580C (https=)
CO (1) CO4980847A1 (https=)
CY (1) CY1106870T1 (https=)
CZ (2) CZ302210B6 (https=)
DE (1) DE69936352T3 (https=)
DK (1) DK1137439T4 (https=)
ES (1) ES2288033T5 (https=)
FR (1) FR2786771B1 (https=)
GB (2) GB9826882D0 (https=)
HK (1) HK1038889B (https=)
HU (2) HU230174B1 (https=)
ID (1) ID29250A (https=)
IL (1) IL143092A0 (https=)
IT (1) IT1319701B1 (https=)
MY (2) MY127579A (https=)
NO (2) NO332698B1 (https=)
NZ (2) NZ511936A (https=)
PE (1) PE20001333A1 (https=)
PL (2) PL196627B1 (https=)
PT (1) PT1137439E (https=)
RU (1) RU2243769C2 (https=)
SG (1) SG151072A1 (https=)
SI (1) SI1137439T2 (https=)
SK (2) SK286688B6 (https=)
TR (2) TR200101416T2 (https=)
TW (2) TWI248938B (https=)
WO (1) WO2000033878A2 (https=)
ZA (1) ZA200104360B (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
MXPA04007847A (es) 2002-02-13 2005-02-24 Biogal Gyogyszergyar Metodo para extraer un macrolido de biomateria.
US7452692B2 (en) 2002-02-13 2008-11-18 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method for extracting a macrolide from biomatter
AR040693A1 (es) * 2002-07-30 2005-04-13 Wyeth Corp Formulaciones parenterales
WO2004089958A2 (en) * 2003-03-31 2004-10-21 TEVA Gyógyszergyár Részvénytársaság Crystallization and purification of macrolides
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
PL1558622T3 (pl) 2003-07-24 2008-06-30 Teva Gyogyszergyar Zartkoerueen Muekoedoe Reszvenytarsasag Sposób oczyszczania makrolidów
KR20060085246A (ko) 2003-09-18 2006-07-26 마커사이트, 인코포레이티드 경공막 전달
US9114198B2 (en) * 2003-11-19 2015-08-25 Advanced Cardiovascular Systems, Inc. Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same
KR20060126701A (ko) * 2003-12-10 2006-12-08 애크럭스 디디에스 피티와이 리미티드 경피 또는 국소 약물 전달에 따른 원치않는 효과의치료방법
US8551512B2 (en) * 2004-03-22 2013-10-08 Advanced Cardiovascular Systems, Inc. Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS
MX2007003731A (es) * 2004-09-29 2007-08-14 Johnson & Johnson Formas de dosis farmaceuticas de compuestos similares a rapamicina amorfos estables.
DK1848431T3 (en) 2005-02-09 2016-04-18 Santen Pharmaceutical Co Ltd LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS
WO2007067566A2 (en) * 2005-12-07 2007-06-14 Wyeth Methods for preparing crystalline rapamycin and for measuring crystallinity of rapamycin compounds using differential scanning calorimetry
US7700614B2 (en) * 2005-12-14 2010-04-20 Abbott Laboratories One pot synthesis of tetrazole derivatives of rapamycin
US20070142422A1 (en) * 2005-12-20 2007-06-21 Wyeth Control of CCI-779 dosage form stability through control of drug substance impurities
KR20140093764A (ko) * 2006-02-09 2014-07-28 산텐 세이야꾸 가부시키가이샤 안정한 제제와 그 제조 및 사용 방법
ES2563288T3 (es) 2006-03-23 2016-03-14 Santen Pharmaceutical Co., Ltd Rapamicina en dosis bajas para el tratamiento de enfermedades relacionadas con la permeabilidad vascular
JP2013527223A (ja) 2010-06-02 2013-06-27 フレゼニウス・カビ・オンコロジー・リミテッド ラパマイシンエステルの安定な医薬組成物
CN103025753A (zh) * 2010-06-07 2013-04-03 泰立克公司 晶体盐酸依泽替米贝非溶剂化物
WO2012017449A1 (en) * 2010-08-04 2012-02-09 Meril Life Sciences Pvt. Ltd Process for preparation of novel 42-0-(heteroalkoxyalkyl) rapamycin compounds with anti-proliferative properties"
ES2753529T3 (es) 2010-11-19 2020-04-13 Biocon Ltd Procesos para la preparación de everolimús y productos intermedios del mismo
JP2014516075A (ja) 2011-06-06 2014-07-07 シェブロン フィリップス ケミカル カンパニー エルピー 癌治療のためのメタロセン化合物の使用
WO2013022201A1 (en) * 2011-08-11 2013-02-14 Dong-A Pharm. Co., Ltd. Process of preparing a stabilized and solubilized formulation of sirolimus derivatives
US9610385B2 (en) 2013-03-07 2017-04-04 Abbott Cardiovascular Systems Inc. Method of fabricating an implantable medical device comprising a rapamycin derivative
IN2013MU02532A (https=) 2013-07-31 2015-06-26 Sahajanand Medical Technologies Pvt Ltd
CN104721158B (zh) * 2013-12-24 2018-01-30 正大天晴药业集团股份有限公司 一种稳定的依维莫司片剂
CN104892632B (zh) * 2015-06-03 2017-12-26 道中道（菏泽）制药有限公司 一种晶体形式的依维莫司及其制备方法
EP3329916A4 (en) 2015-07-28 2019-03-20 Nippon Kayaku Kabushiki Kaisha PHARMACEUTICAL COMPOSITION COMPRISING RAPAMYCIN OR A DERIVATIVE THEREOF, AND PROCESS FOR PRODUCING THE SAME
JP6793651B2 (ja) * 2015-08-28 2020-12-02 日本化薬株式会社 ラパマイシン又はその誘導体を含有する医薬組成物
US20190038605A1 (en) * 2015-09-18 2019-02-07 Nippon Kayaku Kabushiki Kaisha Pharmaceutical composition comprising rapamycin or derivative thereof
WO2017129772A1 (en) 2016-01-29 2017-08-03 Xellia Phamaceuticals Aps Stable pharmaceutical compositions of temsirolimus
WO2017204215A1 (ja) 2016-05-27 2017-11-30 日本化薬株式会社 ラパマイシン又はその誘導体を含有する医薬組成物
KR102051806B1 (ko) * 2018-01-12 2019-12-04 주식회사 종근당 에베로리무스를 포함하는 안정화된 약제학적 제제
EP4126882A1 (en) * 2020-03-27 2023-02-08 Boston Scientific Scimed Inc. Methods for crystallization of drugs
JP2023028473A (ja) * 2021-08-19 2023-03-03 日本マイクロバイオファーマ株式会社 エベロリムスの製造方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0663916A1 (en) * 1992-10-09 1995-07-26 SANDOZ-ERFINDUNGEN Verwaltungsgesellschaft m.b.H. O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA737247B (en) * 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
US3996355A (en) 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
US4049128A (en) 1976-11-18 1977-09-20 Westinghouse Air Brake Company Control system for automatic railway car coupler
AU543727B2 (en) * 1980-06-02 1985-05-02 Ayerst Mckenna & Harrison Inc. Injectable composition of rapamycin
GB8803836D0 (en) 1988-02-18 1988-03-16 Glaxo Group Ltd Compositions
JPH01249651A (ja) † 1988-02-18 1989-10-04 E I Du Pont De Nemours & Co セラミツク／蒸留可能な結合剤組成物
KR0159766B1 (ko) * 1989-10-16 1998-12-01 후지사와 토모키치로 양모제 조성물
JPH04230389A (ja) * 1990-07-16 1992-08-19 American Home Prod Corp ラパマイシン誘導体
FI97472C (fi) * 1991-05-07 1996-12-27 American Home Prod Menetelmä terapeuttisesti käyttökelpoisten rapamysiinijohdannaisten valmistamiseksi anti-inflammatorisina ja antifungaalisina aineina
SG47580A1 (en) 1992-10-13 1998-04-17 American Home Prod Carbamates of rapamycin
US5302584A (en) * 1992-10-13 1994-04-12 American Home Products Corporation Carbamates of rapamycin
RU2181054C2 (ru) * 1994-11-02 2002-04-10 Новартис Аг Микроэмульсионный предконцентрат
US5985890A (en) 1995-06-09 1999-11-16 Novartis Ag Rapamycin derivatives
FR2736550B1 (fr) * 1995-07-14 1998-07-24 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule
PT956034E (pt) * 1996-07-30 2002-12-31 Novartis Ag Composicoes farmaceuticas para o tratamento da rejeicao de transplantes estados inflamatorios ou auto-imunes compreendendo ciclosporina a e 40-o-(2-hidroxietil)-rapamicina
US6362264B1 (en) * 1996-12-20 2002-03-26 Ck Witco Corporation Stabilizer for food contact and medical grade PVC
CA2279259A1 (en) 1997-02-04 1998-08-06 Abbott Laboratories Pain reducing parenteral liposome formulation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0663916A1 (en) * 1992-10-09 1995-07-26 SANDOZ-ERFINDUNGEN Verwaltungsgesellschaft m.b.H. O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants

Also Published As

Publication number Publication date
SK7662001A3 (en) 2001-12-03
GB9826882D0 (en) 1999-01-27
PL348333A1 (en) 2002-05-20
EP1137439A2 (en) 2001-10-04
US20080161334A1 (en) 2008-07-03
NZ511936A (en) 2003-10-31
BE1012869A3 (fr) 2001-04-03
SK287325B6 (sk) 2010-07-07
ES2288033T3 (es) 2007-12-16
PT1137439E (pt) 2007-09-25
CA2732620A1 (en) 2000-06-15
MY127579A (en) 2006-12-29
ITMI992520A1 (it) 2001-06-02
ZA200104360B (en) 2002-01-16
DE69936352T3 (de) 2012-05-03
CY1106870T1 (el) 2012-09-26
US7297703B2 (en) 2007-11-20
US7572804B2 (en) 2009-08-11
HK1038889B (en) 2008-01-25
MY120594A (en) 2005-11-30
RU2243769C2 (ru) 2005-01-10
JP2005200429A (ja) 2005-07-28
US20090270441A1 (en) 2009-10-29
SI1137439T2 (sl) 2012-05-31
SK286688B6 (sk) 2009-03-05
NO20012424D0 (no) 2001-05-16
US7741338B2 (en) 2010-06-22
CA2732620C (en) 2013-08-06
EP2279751A3 (en) 2011-02-16
HUP0104489A3 (en) 2004-05-28
IL143092A0 (en) 2002-04-21
EP1137439B2 (en) 2011-11-23
FR2786771B1 (fr) 2002-12-27
JP5043308B2 (ja) 2012-10-10
SI1137439T1 (sl) 2008-06-30
KR20060096477A (ko) 2006-09-11
CA2351580C (en) 2012-03-20
EP1743657A3 (en) 2007-03-28
JP3805625B2 (ja) 2006-08-02
CA2651609A1 (en) 2000-06-15
NO20012424L (no) 2001-05-16
ID29250A (id) 2001-08-16
CN1261163C (zh) 2006-06-28
CN1876657B (zh) 2013-01-09
AR048073A2 (es) 2006-03-29
TR200101416T2 (tr) 2002-01-21
EP1137439B1 (en) 2007-06-20
US6605613B2 (en) 2003-08-12
CA2351580A1 (en) 2000-06-15
TR200201428T2 (tr) 2002-12-23
AU1657300A (en) 2000-06-26
CN1876657A (zh) 2006-12-13
US20050107418A1 (en) 2005-05-19
DK1137439T4 (da) 2012-03-19
JP2006111637A (ja) 2006-04-27
BR9915986A (pt) 2001-09-04
JP5165199B2 (ja) 2013-03-21
JP2002531527A (ja) 2002-09-24
WO2000033878A2 (en) 2000-06-15
HU228939B1 (en) 2013-07-29
ITMI992520A0 (it) 1999-12-02
HUP0104489A2 (hu) 2002-03-28
DE69936352D1 (de) 2007-08-02
PL196627B1 (pl) 2008-01-31
US6852729B2 (en) 2005-02-08
GB9904934D0 (en) 1999-04-28
DK1137439T3 (da) 2007-09-10
CZ303006B6 (cs) 2012-02-22
SG151072A1 (en) 2009-06-29
EP1743657A2 (en) 2007-01-17
EP2269651A3 (en) 2011-03-09
FR2786771A1 (fr) 2000-06-09
AR026102A1 (es) 2003-01-29
CZ302210B6 (cs) 2010-12-22
CN1374872A (zh) 2002-10-16
KR20010101128A (ko) 2001-11-14
NO334612B1 (no) 2014-04-22
IT1319701B1 (it) 2003-10-27
US20030191148A1 (en) 2003-10-09
NZ527781A (en) 2004-11-26
TW200540179A (en) 2005-12-16
PE20001333A1 (es) 2000-12-12
ES2288033T5 (es) 2012-04-10
NO332698B1 (no) 2012-12-10
HU230174B1 (hu) 2015-09-28
US20020032213A1 (en) 2002-03-14
TWI270550B (en) 2007-01-11
EP2269651A2 (en) 2011-01-05
EP2279751A2 (en) 2011-02-02
TWI248938B (en) 2006-02-11
CZ20012001A3 (cs) 2001-09-12
ATE365051T1 (de) 2007-07-15
WO2000033878A3 (en) 2000-11-02
DE69936352T2 (de) 2008-02-14
PL208854B1 (pl) 2011-06-30
HK1038889A1 (en) 2002-04-04
AU759219B2 (en) 2003-04-10
NO20121113L (no) 2001-05-16
CO4980847A1 (es) 2000-11-27
AR054444A2 (es) 2007-06-27

Similar Documents

Publication Publication Date Title
KR100695834B1 (ko) 마크로리드의 안정화 방법
RU2264405C2 (ru) 40-o-(2-гидрокси)этилрапамицин в кристаллической несольватированной форме, фармацевтическая композиция, содержащая такой макролид в качестве действующего вещества, и способ его получения
AU2003200370B2 (en) Stabilization of macrolides
HK1151741A (en) Stabilisation of macrolides
HK1146246A (en) Stabilisation of macrolides
HK1102910A (en) Stabilisation of macrolides
MXPA01005720A (en) Macrolides

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20010605

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20041206

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20060627

Patent event code: PE09021S01D

A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20060828

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20061218

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20070309

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20070312

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20100223

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20100223

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20110217

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20110217

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20120221

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20120221

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20130221

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20130221

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20140220

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20140220

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20150224

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20150224

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20160218

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20160218

Start annual number: 10

End annual number: 10

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20160330

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20070309

Comment text: Registration of Establishment

Decision date: 20180223

Request date: 20160330

Appeal identifier: 2016100000902

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Decision date: 20180112

Request date: 20160414

Appeal identifier: 2016100000957

Appeal kind category: Confirmation of the scope of right_defensive

Patent event code: PJ02062R01D

Patent event date: 20160414

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20070309

Comment text: Registration of Establishment

Decision date: 20180223

Request date: 20160414

Appeal identifier: 2016100000950

Appeal kind category: Confirmation of the scope of right_defensive

FPAY Annual fee payment

Payment date: 20170302

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20170302

Start annual number: 11

End annual number: 11

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20170707

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20070309

Comment text: Registration of Establishment

Decision date: 20171222

Request date: 20170707

Appeal identifier: 2017100002134

Appeal kind category: Confirmation of the scope of right_defensive

J301 Trial decision

Free format text: TRIAL NUMBER: 2017100002134; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20170707

Effective date: 20171222

PJ1301 Trial decision

Patent event code: PJ13011S02D

Patent event date: 20171222

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20170707

Decision date: 20171222

Appeal identifier: 2017100002134

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20180112

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2016100000957

Request date: 20160414

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20180112

PJ2001 Appeal

Patent event date: 20171222

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Patent event code: PJ20011S02I

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20190215

Appeal identifier: 2018200001820

Request date: 20180207

J301 Trial decision

Free format text: TRIAL NUMBER: 2016100000950; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20160414

Effective date: 20180223

Free format text: TRIAL NUMBER: 2016100000902; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20160330

Effective date: 20180223

PJ1301 Trial decision

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20160414

Decision date: 20180223

Appeal identifier: 2016100000950

Patent event code: PJ13011S02D

Patent event date: 20180223

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20160330

Decision date: 20180223

Appeal identifier: 2016100000902

FPAY Annual fee payment

Payment date: 20180228

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20180228

Start annual number: 12

End annual number: 12

PJ2001 Appeal

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20190215

Appeal identifier: 2018200003840

Request date: 20180430

Patent event date: 20180223

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Patent event code: PJ20011S02I

Patent event date: 20171222

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Patent event code: PJ20011S02I

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20190215

Appeal identifier: 2018200003819

Request date: 20180430

FPAY Annual fee payment

Payment date: 20190227

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20190227

Start annual number: 13

End annual number: 13

PJ2002 Appeal before the supreme court

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Patent event date: 20180223

Patent event code: PJ20021S02I

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Patent event date: 20171222

Patent event code: PJ20021S02I

Request date: 20190313

Appeal identifier: 2019300010401

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20190830

J302 Written judgement (patent court)

Free format text: TRIAL NUMBER: 2018200003819; JUDGMENT (PATENT COURT) FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20180430

Effective date: 20190215

Free format text: TRIAL NUMBER: 2018200003840; JUDGMENT (PATENT COURT) FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20180430

Effective date: 20190215

PJ1302 Judgment (patent court)

Request date: 20180430

Decision date: 20190215

Appeal identifier: 2018200003840

Appeal kind category: Confirmation of the scope of right_defensive

Patent event date: 20190401

Comment text: Written Judgment (Patent Court)

Patent event code: PJ13021S01D

Request date: 20180430

Decision date: 20190215

Appeal identifier: 2018200003819

Appeal kind category: Confirmation of the scope of right_defensive

J302 Written judgement (patent court)

Free format text: TRIAL NUMBER: 2018200001820; JUDGMENT (PATENT COURT) FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20180207

Effective date: 20190215

J303 Written judgement (supreme court)

Free format text: TRIAL NUMBER: 2019300010401; JUDGMENT (SUPREME COURT) FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20190313

Effective date: 20190830

PJ1302 Judgment (patent court)

Patent event date: 20190906

Comment text: Written Judgment (Patent Court)

Patent event code: PJ13021S01D

Request date: 20180207

Decision date: 20190215

Appeal identifier: 2018200001820

Appeal kind category: Confirmation of the scope of right_defensive

PJ1303 Judgment (supreme court)

Comment text: Written Judgment (Supreme Court)

Patent event date: 20190906

Patent event code: PJ13031S01D

Decision date: 20190830

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20190313

Appeal identifier: 2019300010401

EXPY Expiration of term
PC1801 Expiration of term